Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

374 ARTÍCULOS , VIENDO DEL 361 AL 374

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Ganguly G, Chakrabarti S, Chatterjee U, Saso L.

Drug Des Devel Ther. 2017 Mar 16;11:797-810. doi: 10.2147/DDDT.S130514. eCollection 2017.

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF.

CNS Neurol Disord Drug Targets. 2017;16(4):387-397. doi: 10.2174/1871527316666170328113309.

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Chiti F, Dobson CM.

Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Li Y, Zhao J, Hölscher C.

CNS Drugs. 2017 Aug;31(8):639-652. doi: 10.1007/s40263-017-0451-y.

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

Radad K, Moldzio R, Al-Shraim M, Kranner B, Krewenka C, Rausch WD.

CNS Neurol Disord Drug Targets. 2017;16(7):740-748. doi: 10.2174/1871527316666170623094728.

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

Lazarevic-Pasti T, Leskovac A, Momic T, Petrovic S, Vasic V.

Curr Med Chem. 2017;24(30):3283-3309. doi: 10.2174/0929867324666170705123509.

Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease

Itoh Y, Voskuhl RR.

PLoS One. 2017 Jul 17;12(7):e0181349. doi: 10.1371/journal.pone.0181349. eCollection 2017.

Dietary Modulation of Oxidative Stress in Alzheimer's Disease

Thapa A, Carroll NJ.

Int J Mol Sci. 2017 Jul 21;18(7):1583. doi: 10.3390/ijms18071583.

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Alam Q, Alam MZ, Sait KHW, Anfinan N, Noorwali AW, Kamal MA, Khan MSA, Haque A.

Curr Drug Metab. 2017;18(9):868-876. doi: 10.2174/1389200218666170728115606.

Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

Apostolakis S, Kypraiou AM.

Rev Neurosci. 2017 Nov 27;28(8):893-911. doi: 10.1515/revneuro-2017-0020.

[Memantine: from the original brand to generics]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.

Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects

Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M.

J Neurol Sci. 2017 Feb 15;373:210-215. doi: 10.1016/j.jns.2016.12.046. Epub 2016 Dec 29.

Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?

Jodeiri Farshbaf M, Ghaedi K.

Biometals. 2017 Feb;30(1):1-16. doi: 10.1007/s10534-016-9981-x. Epub 2016 Nov 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias